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by Susan M. Brett,* Joseph V. Rodricks,* and
Vernon M. Chinchillit
Since the 1980U.S. Supreme Courtdecision onthe Occupational Safety andHealthAdministration's (OSHA)
proposal to lower the occupational benzene standard from 10ppm to 1 ppm, numerous quantitative assess-
ments ofthe leukemia risk ofbenzene exposure have been prepared. The primary difference between these
risk assessments has been in the way in which benzene exposure has been estimated and in the models ap-
plied to describe the dose-response relationship. The more recentassessments, in attemptingto estimate ben-
zeneexposures on an individual basis, andin applyingmodels which make maximal use ofthe availabledata
points, represent asubstantial improvement overearlierassessments. Inthispaper, we will reviewtheavail-
able risk assessments and the data upon which they are based and will present our own assessment, which
buildsonpriorefforts. Ourreevaluation oftheunderlyingdataonthecohortthatwejudgedtobemostsuitable
for quantitative risk analysis suggested that past assessments may have overestimated risk by a factor of
3 to 24. In addition, we will present some recentlymade available dataofrelevance to the benzene exposure
histories ofcohort ofconcern. These data provide additional suggestion that the total benzene exposure of
certain members ofthis cohort has likely been seriously underestimated, the extentto which remains to be
determined. Further analysis ofthese data and pursuit ofadditional sources to improve the characteriza-
tion ofthe benzene exposure of this cohort appear to be warranted in order to define more precisely the
benzene-leukemia dose-response relationship.
Introduction
The hazards of benzene exposure to humans and ex-
perimental animals are well documented (1-3). In hu-
mans, exposure tohigh levels ofbenzene has caused a va-
riety of disorders ofthe hematopoietic system, particu-
larly leukemia, especially ofthe acute myelogenous type,
and aplastic anemia(1,2,4). Evidence oftheleukemogenic
properties ofbenzene has come both from collections of
case reports (3-6) andfromepidemiological studies(7-9).
There is no substantial disagreement in the scientific
community thatbenzene exposure can cause leukemiain
highly exposed humans. What does remain uncertain,
however, is the relationship between aparticularlevel of
benzene exposure and the resultingprobability ofdevel-
opingleukemia. This uncertainty results from incomplete
data on the levels ofbenzene to which individuals in the
epidemiologic studies were exposed and a number of
other factors that affect the dose-response relationship.
Elevated frequencies of chromosome aberrations in
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bone marrow cells and peripheral leukocytes have been
observed in a number of studies ofindividuals exposed
to benzene (1). It is not clear whether these are signifi-
cant indicators ofhealth damage. Studies of the effects
ofbenzene exposure in animalshave shown some similar-
itiesto, and also some significant differencesfrom, the ef-
fects observedinexposedhumans. Aswith humans, the
hematopoietic system inthe bone marrow is a critical tar-
getofbenzene exposure, withanemia, lymphocytopenia,
and bone marrow hypoplasia as common responses to
repeated inhalation of benzene in the 100 to 300 ppm
range(1). Also,mice andrabbitsexposed tobenzene show
increased numbers of chromosome aberrations in their
bone marrow.
Themajordifference inresponsebetweenhumansand
the species and strains ofexperimentalanimalsthathave
been tested is that, although several cases of leukemia
have been attributed to benzene exposure by some re-
searchers, no animal model forbenzene-induced leukemia
has been well established. Several other forms of ne-
oplasms havebeenfound atelevatedincidence in rats and
mice exposed tobenzenebyinhalation oringestionhow-
ever (10-15). The sites at which tumors have been
elevated in rodents include the Zymbal gland, the oral
cavity, the preputial gland, the Harderian gland, the
mammarygland, thelung, andovaries, inadditiontolym-BRETT, RODRICKS, AND CHINCHILLI
phomas and leukemia. The reasons for the differences in
response between species are not known, though in-
terspecies differences in metabolism and pharmacoki-
netics of benzene via different routes of exposure may
contribute.
The findings in experimental animals confirm qualita-
tively the carcinogenic potential ofbenzene. However, it
would be inappropriate to rely on such data to estimate
quantitatively the risks of exposure of humans to ben-
zene. Most expert groups, including, OSHA (16), U.S.
EPA (17,19), and the Office of Science and Technology
Policy (18) agree that where epidemiologic data of
reasonably good quality are available, they should be
usedforrisk assessment. Thus, although itmaybe ofin-
terest for the purpose of comparison to use the animal
data, greatest reliance shouldbeplaced onthe more rele-
vant human data when such data are available.
In 1977, OSHA first proposed to lower the occupational
benzene standard from 10 ppm to 1 ppm on the basis of
its qualitative assessment of the leukemia risks ofben-
zene exposure. Apermanent standardwas, however, not
upheld by the United States Supreme Court on the ba-
sis that OSHA had not demonstrated that a significant
risk existed at the current standard, nor that this risk
would be significantly reduced by institution ofthe pro-
posed standard. Since this Supreme Court decision, quan-
titative risk assessments have been prepared by a num-
ber of investigators. In addition, exposure data of
relevance to the benzene leukemia dose-response rela-
tionship have recently become available and should be
considered when evaluating this issue.
In the following discussion, we will initially review the
epidemiologic data sets available forbenzene risk assess-
ment and will consider factors arguing for and against
theirapplication forthispurpose. Wewillthenreviewthe
assessments that have been prepared and their associ-
ated strengths and limitations. The data recently made
available and their potential effect on the available ben-
zene risk estimates will be discussed. Finally, on the ba-
sis ofthis analysis, our conclusions regarding leukemia
risk associated with occupational benzene exposure will
be presented.
Epidemiologic Studies Available for
Risk Assessment
A number ofepidemiologic studies have been used to
assess the risk ofleukemiamortality to persons exposed
to benzene. We will describe the four studies that have
been most frequently usedforthis purpose andtheir as-
sociated strengths andlirnitations forquantitative riskas-
sessment.
Description of Studies and Their
Limitations
Infante et al. andRinsky et al. Infante et al. (1) and
Rinsky et al. (9,20,21) arereportsrepresentingcontinued
follow-up oftheleukemiamortalityexperience ofagroup
ofGoodyear workers who had been exposed to benzene
in the manufacture ofrubber hydrochloride (also known
as Pliofilm) at three facilities at two locations in Ohio. We
shall limit our discussion to the methodology and results
obtainedin the lattertwo Rinsky reports, as these have
been the primary basis for the more recent risk assess-
ments.
Rinsky et al. (9) divided the Pliofilm cohort from the
three facilities into two groups according to the time
period worked in the Pliofilm department. Group 1 con-
sisted of 748 workers who worked at least one day be-
tween January 1, 1940, and December 31, 1949; group 2
consisted of258workers whosefirst Pliofilm exposure oc-
curredbetweenJanuary 1, 1950, and December 31, 1959.
Vital status was ascertained to June 30, 1975, for98% of
the cohort. For each group, the number ofworkers who
died from leukemia between January 1, 1950, and June
30, 1975, was compared tothe expectednumberbased on
U.S. white male mortality using a modified life table ap-
proach.
Among the 748 workers in the first group, 7 deaths
fromleukemia occurred versus 1.25leukemia deaths ex-
pected, resultingin a standardized mortality ratio (SMR)
of560 (p < 0.001). It was noted that the mean duration
ofbenzene exposure was relatively brief, with 437 per-
sons (58%) of the cohort exposed for less than 1 year.
Upon dataanalysisbylengthofemployment, a significant
excess in leukemia was observed among workers em-
ployed 5 or more years (5 leukemia deaths observed vs.
0.23 expected, SMR=2100), but not amongworkers em-
ployedforless than 5 years (2 leukemia deaths observed
vs. 1.02 expected, SMR=196, not statistically significant).
Amongthe 258workers inthe secondgroup, only 1 death
fromleukemiawasobservedvs. 0.46expected, represent-
ing an increase that was not statistically significant.
Rinsky et al. (21) expanded the Pliofilm cohort by in-
cluding all nonsalaried, white males employed in a
Pliofilm department at the two locationsforat least 1 day
between January 1, 1940, and December 31, 1965 (i.e., 6
additional exposureyears). Vital statuswas ascertained
through December31, 1981(6.5 additionalyears offollow-
up). This resulted in a total cohort of 1165 white males
with atleast 1 ppm-day(1 dayofemployment in aPliofilm
department with atleast 1 ppm average benzene concen-
tration) of cumulative benzene exposure.
In this cohort, a total of 9 leukemia deaths was ob-
served vs. 2.7 expected, resulting in an SMR of337(95%
CI=154-641). Thus, during the additional 6.5 years of
follow-up ofthe original Rinsky et al. (9) 1981 cohort, 1
additional leukemia death was observed; no leukemia
deaths were observed in the subgroup ofworkers whose
employment began after 1959.
Rinsky et al. (21) further refined their analysis by
stratifying the cohort by cumulative benzene exposure.
To develop estimates of cumulative benzene exposure,
they created 10broad exposure classes, each associated
with a specific job title in the Pliofilm operation. They
then constructedjob-exposurematrices, whichassociated
an average annual benzene exposure level with each ex-
posure class.
Rinskycalculated cumulativebenzene exposure over a
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workinglifetime foreachindividual baseduponestimated
benzene concentration in a Plioflimjob category during
the particularyear(s) ofexposure and the duration ofex-
posure in particular jobs. The cohort was then divided
into four cumulative exposure categories: 0.001-40 ppm-
years; 40-200ppm-years; 200400ppm-years; andgreater
than 400 ppm-years, with SMRs of 109, 322, 1186, and
6637, respectively.
In addition, Rinsky et al. (21) performed a matched
case-control analysis using conditional logistic regression.
This aspect of the Rinsky et al. 1987 report will be dis-
cussed later in thispaper when the available riskassess-
ments on benzene are reviewed.
There are number oflimitations to this study, many of
which relate to the characterization of exposure. First,
environmental monitoring datafor the twolocations were
significantly less than complete for the years under con-
sideration. For location 1, the location on which the
majority of data was available, there were no measure-
ments available for the years prior to 1946 or for the
years 1951 to 1963. In 1963, the companybegan to record
benzene concentrations on a standard form. The fre-
quency ofcompany surveys for atmospheric benzene for
the years 1963 to 1971, however, was quite low, with an
average ofonly 2.3 surveys/year during this time inter-
val, and anaverage ofonly2.3 samples/yearcollectedfor
each ofthe 12workareas considered. Thus, evenforthe
plant location at which monitoring datawere more read-
ily available, the body of evidence may be considered
somewhat limited.
Environmental monitoring results for location 2 were
extremely limited. Forplant 1 (oflocation 2), only three
sample points, determined in an industrial hygiene sur-
vey on one day in 1948, were available. Similarly, for
plant 2(oflocation2), the only environmental dataavail-
able were believed to have been taken "around 1957."
Thus, apparently no sampling datawere available for27
ofthe 29 years during which Pliofilm was manufactured
at this location. Rinsky et al., forlack ofbetter monitor-
ing data, made the assumption that benzene exposures
at location 2 were similar to those at location 1. This as-
sumption has notbeen verified. This maybe particularly
significant because it suggests thatforgreater than 40%
ofthe overall cohortandtwo-thirds oftheleukemiacases,
no directly applicable monitoring data were available
upon which to base worker exposures.
These significantgaps inthe available benzenemonitor-
ing data for location 2 in general, and for many of the
years under consideration for location 1, necessitated
making a large number ofassumptions in the investiga-
tors' attempts to estimate individual cumulative benzene
exposure, Clearly, this is anissue ofgreatimportance if
onerelies onthis study to assessbenzene-leukemiadose-
response relations.
Another area of uncertainty relates to the fact that
Rinsky et al. failed to consider all routes ofbenzene ex-
posure in this cohort ofPliofilm workers. Duringthe 1977
OSHA hearings on benzene, testimony was presented
suggesting that dermal exposure in certain work areas
in the Pliofilm plants was significant. The Rinsky et al.
study, however, did not report on these exposure condi-
tions, nor did it consider that the dermal route might
have contributed significantly to total benzene exposure
of certain workers in the cohort. The possible contribu-
tion to total benzene exposure from the dermal route will
be considered later in this paper.
Rinsky et al. did not considerthe extentofbenzene ex-
posurethat members ofthe Pliofilm cohortmayhave had
in non-Pliofilmjobs within the Goodyearplants. Through
a Freedom of Information Act request, the American
Petroleum Institute (API) has recently obtained the
Goodyearjob history records ofthe Rinsky cohort mem-
berswho have died. Review ofthesejob history records
indicates that most members ofthe cohort worked in a
variety of non-Pliofilm jobs throughout the Goodyear
plants, many ofwhich likely involved substantial benzene
exposure. As will be discussed, a review of some early
published reportsby medical personnel ofGoodyear sug-
gests that pure benzene or solvents with high benzene
concentrations were used by the company in several of
these non-Pliofilm operations. On the basis of these
reports it is suggested that the total benzene exposure
ofthe Pliofilm cohort may have been seriously underes-
timatedby the failure to consider exposure, both by the
inhalation and dermal routes, to benzene in non-Pliofilm
jobs throughout the Goodyear plants involved in the
study.
Ofthe 9 leukemias observedin the overall cohort, 6had
worked in location 2. This may be important because lo-
cation 2 is that for which almost no environmental
monitoring data were available for the Pliofilm opera-
tions. The higher rate ofleukemia mortality in location
2 than in location 1 may be related to the higher poten-
tial for benzene exposure in the tire-building (non-
Pliofilm)job areas oflocation 2. The investigations made
the assumption, however, thatbenzene exposures at the
two locations were very similar. This assumption may
have been in error.
Ottetal. andBondetal. Ott et al. (8) studiedthe mor-
tality experience of594 white males who were exposed
to benzene in three production areas of Dow Chemical
Company in Michigan. The workers had been employed
at the plant between 1940 and 1973, with no apparent
minimumlength ofemploymentrequired for inclusion in
the cohort.
Benzene concentrations in the three production areas
(i.e., chlorobenzol, alkylbenzene, andethylcellulose)were
characterizedbaseduponenvironmental monitoringdata
from 1944 to 1973. Overall, benzene levels ranged from
0 to937ppm, althoughthe estimatedtime-weightedaver-
age benzene concentrations rangedfrom 0.1 to35.5ppm
in the various job categories. Exposures were further
categorizedforspecificjobs inthe production areasbased
upon time-weighted average benzene exposure. A total
of 3 leukemia cases was observed from 1940 to 1973
versus 0.8expected, basedupon incidence datafrom the
Third National Cancer Survey. Thisresulted in an SMR
of 375.
There are anumberoffactors thatlimitthe usefulness
ofthis study forthepurpose ofleukemiariskassessment.
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First, it must be considered that workers at the Michi-
gan Dow plantwere reportedly exposed to a large num-
ber of chemicals in addition to benzene, some of which
have been associated with carcinogenic effects. Thislack
ofspecificity ofexposure may have had a significant in-
fluence on the study results. This concern is magnified
upon examination ofthe work exposure histories ofthe
three leukemia cases, all ofwhom had documented mul-
tiple chemical exposures in past employment.
Another limitation ofthe study, in terms ofits utility
forestablishing causal associations, wasthelackofanob-
served dose-response relationship. In addition, the small
size ofthe Ott et al. (8) study makes it ofsomewhat lim-
ited use for the purpose ofrisk assessment. Due to the
small study size, the standardized morbidity ratio of375
that was observed for leukemia had a95% confidence in-
terval that ranged from approximately 77 to 1096. This
interval wouldgenerally be considered tobe too wide to
provide confidence in the use ofthe SMR of375 astheba-
sis for quantitative risk estimates.
This investigation hasbeenrecently updated in an un-
publishedreportby Bond et al. (22). Inthis analysis, 956
DowMichigan division employees potentially exposedto
benzene were studied. The period of observation was
1940 to 1982, representing anadditional 9years offollow-
up from the earlier investigation. Four leukemia deaths
were observed versus 2.1 expected based upon U.S.
white male mortality rates; this increase was not statisti-
cally significant. It was noted, however, that all 4 leuke-
mias were ofthe myelogenous type. When the mortality
formyelogenous leukemia was comparedwith thatwhich
would be expected based upon National Cancer Institute
Surveillance, Epidemiology End Results(SEER)data, a
statistically significant excess was observed (4 observed
vs. 0.9 expected; p = 0.011). The investigators noted a
fifth leukemia case, who was the same individual whose
death certificate was classified to pneumonia in the Ott
et al. (8) study. Thus, thisupdate identified two additional
leukemia deaths amongbenzene-exposed Dow Chemical
workers.
The Bond et al. (22)update has the same limitations for
use inrisk assessment asthe earlier study ofthe cohort.
Once again, the analysis failed to show a positive dose-
responserelationship. Thenumber ofleukemias observed
remains small, and consequentlythe confidence interval
around the risk estimate remains quite wide. The possi-
ble influence ofadditional exposures remains an impor-
tant issue for consideration.
A conditional logistic regression case-control analysis
of the Ott et al./Bond et al. studies (8,22) has been con-
ducted by the American Petroleum Institute in order to
investigate whether they represent evidence of a rela-
tionship between increasing cumulative benzene ex-
posure and increasing risk ofleukemia (23). The method
of analysis was consistent with that employed in the
Rinsky et al. (20,21) case-control study. Each leukemia
case was matched to 10 controls on date ofbirth and date
offirst employment in abenzene exposurejob. Onthe ba-
sis ofthese analyses, there was not a statistically signif-
icant relationship observed between increasing cumula-
tivebenzene exposure andincreased riskofleukemia(23).
Aksoy. Aksoy (6) reported that during 1967 to 1975, a
total of34 workers at shoe manufacturingfacilities where
benzene was used were admitted to the hematology
departments ofamedical school in Istanbul, Turkey. The
total number ofshoe workers in Istanbul was estimated
to be 28,500. The crude annual incidence ofleukemia in
this population was estimated to be 13/100,000 person-
years ofobservation. The annual incidence rate ofleuke-
miain the general populationwas reportedby the inves-
tigators to be 6/100,000. The observed incidence was
reported to be significantly higher(p < 0.01) thanthein-
cidence in the general population.
The Aksoy studyreportedly evaluates the incidence of
leukemia among28,500 shoe workers in Istanbul. Infact,
a study of 28,500 shoe workers was not actually per-
formed. Aksoy's study population represents a case
series of 34 shoe workers who were admitted to the
hematology departments ofIstanbulMedical School with
a diagnosis ofleukemiabetween 1967 and 1975. The fig-
ure of28,500 was taken from "official records" ofIstan-
bul, which indicate that there are 28,500 workers in-
volved in the shoe, slipper, and handbag industry in
which benzene is used as a solvent. Thus, the leukemia
incidence in only a small percentage ofthe Istanbul shoe
worker population was'actually directly examined.
For a standard population, Aksoy used data on the
leukemiamortality in the general population ofWestern
nations, which he obtained from a paper by Gunz (24).
Aksoy indicated during the 1977 OSHAhearings thatthe
leukemiaincidence rate of2.5 to3/100,000 forthegeneral
populationofTurkeywasnotused intheanalysisbecause
vital statistics reporting in Turkey could not be relied
upon to draw scientific conclusions.
Questions have been raised about the use ofthe Gunz
rate as a standard, however, because it was actually an
estimate of the leukemia mortality rate in Western na-
tions, as opposed tothe leukemia incidence rate thatwas
being estimated in Aksoy's population. An additional
question in the interpretation ofAksoy's results was the
fact that his calculation used crude rates, without adjust-
mentforvariations in age orleukemia cell types. Leuke-
miarates are known to varywidelywith age, thereby re-
quiring that comparisons be made between populations
withreasonably similar age distributions, orthat age ad-
justment be performed prior to relative risk ascertain-
ment.
Perhaps the area ofgreatestuncertainty in the Aksoy
study wasthatofcharacterization ofexposure. One must
assume that these shoe workers were exposed to a mix-
ture ofvolatile hydrocarbons, including benzene. In ad-
dition, workers may have beenexposed to curingagents,
dyes, and other chemicals commonlyusedin the shoe in-
dustry. The leukemic effect observedmay therefore have
been related to these other chemical exposures ortoben-
zene activity in combinationwiththesematerials. The ex-
posure dataprovidedin the Aksoy studies were also very
limited. Aksoy (25) indicated that the concentration of
benzene was foundtoreach amaximumof210 to 650ppm
when adhesives containingbenzene were in use. During
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the OSHA benzene hearings in 1977, Aksoy indicated
thatthe concentration ofbenzene rangedbetween 15and
30 ppm outside working hours and between 150 and 210
ppm during working hours. The number of mea-
surements upon which these ranges ofbenzene concen-
trations were based was not specified in any of the
reports. It is most likely, however, that only a very small
percentage ofthe workplaces under consideration were
actually sampled. Applyingthese environmental datato
the entire cohort, therefore, results inaveryhigh degree
ofuncertainty in any projected exposure-related leuke-
mia risks.
In addition, the Aksoy studies did not consider the is-
sue ofdermal exposure tobenzene. One canassume, how-
ever, that dermal exposure in this occupational setting
may have been substantial. Inlight ofrecent experimen-
tal evidence that suggests that dermal exposure to ben-
zene can result in a high degree of absorption, it would
be best advised that this matter be further investigated
to determine the likely contribution ofdermal exposure
to the total benzene exposure of this cohort.
Wong. Wong (26) conducted a historical prospective
mortality study ofagroup of4602 male chemical workers
from seven plants who were occupationally exposed to
benzene for at least 6 months between 1946 and 1976.
They were compared to a group of 3074 male chemical
workers from the same plants, but with no occupational
exposure to benzene. The vital status oftheworkers was
followed through December 1977 andunderlying causes
of death coded to the 8th Revision ofthe International
Classification of Diseases. Cause-specific mortality was
assessedusinga)the comparisongroup to obtainrelative
risks and the corresponding Mantel-Haenszel chi-square
with one degree offreedom, and b) the U.S. male popu-
lation as a comparison for obtaining SMRs.
For leukemia, the SMR for the exposed group was
117.4(7 deaths observed vs. 5.96expected). This increase
was not statistically significant. Therelative riskofleuke-
miacouldnotbe determinedinthe exposedgroup as com-
pared to the nonexposed group, however, as no deaths
from leukemia were observed in the internal control
population. The reason forthis deficit inleukemia in the
unexposed group remains unknown.
The exposed cohort was divided into categories based
upon an exposure classification ofjobs. In the continuous
exposure group a total of 6 deaths from leukemia were
observed vs. 4.43 expected, yielding an SMR of 135,
which was not significant at the 0.05 level. In the inter-
mittent category, a deficit inleukemia occurred with only
1 leukemia death observed vs. 1.49 expected.
It should be noted that none ofthe leukemia deaths in
the exposed cohort were ofthe acute myelogenous type,
the cell type that has been most commonly associated
with benzene exposure in other occupational studies.
Rather, 4 of the leukemias were lymphatic, 2 were
chronic myeloid, and 1 was an acute leukemia (type un-
specified).
The study has a number oflimitations, some ofwhich
were acknowledgedby theinvestigators. First, it should
be noted that each plant collected data on its own work-
ers. Consequently, it is likely that there was a lack of
uniformity in data collectionprocedures, whichmayhave
biased the results. Second, data on benzene exposures
during the early part of the study were reported to be
limited for some ofthe plants, necessitating estimation
ofexposures onthebasis ofuniform tasksinthe majority
ofplants studied. Two oftheplants, however, didnotuse
this approach, and estimates ofexposures were derived
by supervisors or industrial hygienists. This lack ofcon-
sistency inthe methodologyforexposure estimationmay
have further biased the study results, the direction of
such bias beingimpossible to determine. Third, workers
inthe study wereprobably exposed to alarge variety of
additional chemicals in their studiedjobs(and inpast em-
ployment), which may have influenced study results.
Fourth, relative riskofleukemia couldnotbe determined
betweenexposedandnonexposed workers, as therewere
noleukemias observed in the unexposedgroup. Fifth, the
numberofleukemia deathswas quite small, limitingthe
confidence that canbe placed in any assessment ofdose-
response relationships. Sixth, two ofthe nine plants that
originally participated in the early stages of the study
reportedly withdrew from the study because ofdifficul-
ties in data collection and inparticipation in the study as
designed. This occurred after the collection ofdeath cer-
tificates, raisingthe suspicion thatthe data contained in
the death certificates themselves may have been related
to the decision to no longer participate in the study. It
should further be noted that during the OSHA benzene
hearings held in March of 1986, Wong indicated that in
hisjudgment the inadequacies in the benzene exposure
estimates made the Wongstudy(26) an inadequate basis
for quantitative risk assessment.
Conclusion
This review has emphasized datafrom epidemiological
studies that might be suitable for use in assessing
benzene-associated leukemia risk. On its basis, we con-
clude that the Rinsky et al. (20,21) cohort provides the
best basis for estimation ofbenzene-associated leukemia
risk. In ourjudgment, no other available study is suitable
for risk assessment, primarily because ofageneral lack
of quantitative exposure information.
Although there are significant limitations in the data
onthemagnitude ofexposures ofthe Rinsky etal. cohort,
it nevertheless appears possible to estimate a dose-
response curve (or range of curves) with the degree of
reliability usually considered appropriate for such
studies. We note, however, that some additionalinforma-
tion on the exposures experienced by the Rinsky et al.
cohort has recently become available thatmay affect es-
timates of risk derived therefrom.
Review of Available Benzene Risk
Assessments
Alarge numberofassessments ofthe risk ofleukemia
associated with benzene exposure have been published
sinceOSHAfirstproposeditsstandardin 1977. Inthefol-
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lowing discussion, these risk assessments will be consid-
ered, beginningwiththe earlier assessments, allofwhich
employ similarmethodology, followedby the more recent
assessments that have attempted to make some distinct
improvements in exposure characterization and conse-
quent estimates of risk.
Earlier Risk Assessments Employing the
Linear Model
The Carcinogen Assessment Group of the United
States Environmental Protection Agency presented the
first major risk assessment toliowing the 1977 OSHA
hearings (2?). It considered three sets of occupational
epidemiology data, namelythe studies ofInfante etal. (7),
Aksoy(25,28,29), and Ott etal. (8). EPAassumed that for
low exposures, the lifetime probability of death from
leukemia may be represented by the linear equation:
P = A + Ox (1)
whereA is the rate ofleukemia mortality in the absence
of benzene exposure and x is the average lifetime ex-
posure to benzene in parts per million. The term P rep-
resents the increase in the leukemia mortality rate due
to each increase of 1 ppm average lifetime exposure to
benzene; this term may also be referred to as the slope
of the dose-response relation.
EPA assumed that the relative risk ofleukemia is in-
dependent ofthe duration ofexposure orthe age atwhich
exposure occurs in the worker population. Given this
assumption, through several algebraic transformations,
P can be derived as follows:
( _ P1(R - 1)/X2 (2)
where Pi is the lifetime probability ofdying ofleukemia
with no ornegligible benzene exposure, R is the relative
risk of leukemia for a benzene-exposed worker cohort
compared to thegeneralpopulation, and X2iS the cumula-
tive occupational exposure to benzene, averaged over a
lifetime.
At least six additional risk assessments were subse-
quently developedby othergroups, all accepting EPA's
general model (30-35). These risk assessments differed
primarily in theirjudgment ofthe adequacy for risk as-
sessment of the three studies originally considered by
EPA, andintheirchoice ofvalues for Pi, R, and X2 to be
used in deriving P; several ofthe assessments rejected
the Aksoy and Ott data sets entirely. This resulted in
these assessments producing a wide range ofestimates
forthe slope Pofthelineardose-response function atlow
doses.
Because ofthe limitations ofthe Ott et al. (8) and the
Aksoy studies (6,25,28,29) as described above, it is our
judgment that ofthe three epidemiologic data sets con-
sidered in these risk assessments, the Infante et al. (7)
and Rinsky et al. (9) dataare thebest suitedforquantita-
tive risk assessment. Consequently, for the remainder of
this discussion ofthese seven risk assessments based on
the linearmodel, the results presented will be limited to
those derived from the Infante et al. (7)and Rinsky et al.
(9) studies.
Table 1 presents the ranges ofadditional lifetime leuke-
mia deathspredictedduetooccupational exposure toben-
zene in these seven riskassessments based upon the In-
fante et al. (7) and Rinsky et al. (9) data. Risks are
predicted specifically for workers exposed at the former
10 ppm standard for 45 years(450 ppm-years) and at the
new 1-ppm standard for 45 years (45 ppm-years),
assuming an average 70 year lifetime.
Because of variations in these risk assessments in
values selectedforPI,R, and X2, theresultantpredictions
ofrisk at 45 and 450 ppm-years varied by a factor ofap-
proximately 8. Variations inassumptions aboutexposure
(X2) had the greatest influence upon the range of
predicted leukemias in benzene-exposed workers. Differ-
ences inassumptions aboutbackgroundprobabilities and
relative risks in the Infante/Rinsky cohort had afarless
significant influence.
Table 1. Comparision of risk assessments using a linear model based on epidemiological data of
Infante et al. (7) or follow-up reported by Rinsky et al. (9).
Assessment
U.S. EPA (27)
API/Lamm (30)
Hattis and Mendez (31)b
IARC (32)c
Luken and Miller (33)
A. D. Little (Gilbert) (34)b
ELI (35)
Relative
risk
9/1.25 = 7.2
7/1.25 - 5.6
9/0.84 = 10.7
7/1.25 = 5.6
7/1.25 = 5.6
9/0.84 = 10.7
7/1.25 = 5.6
Average lifetime
exposure, ppm
2.81
2.81
0.84
N.A.
1.30
3.27
Low 0.37
High 0.88
Assumed
background
probability
0.006732
0.006732
0.004517
0.007
0.006732
0.00452
0.006732
Lifetime risk
for an average
lifetime exposure of 1 ppma
0.015
0.011
0.052
0.009-0.037
0.024
0.013
0.084
0.035
Additional lifetime leukemia
risk/1000 workers due to
benzene exposure
45 ppm-years 450 ppm-years
2.1 21
1.6 16
7.4 74
1.4-1.7 14-17
3.3 33
1.88 18.8
4.9-11.8 49-118
'All based on a linear model of the dose-response relation. Note that IARC did not project the estimated slopes beyond the range of observed
dose-response relations.
"These authors use background rates for nonlymphatic leukemias only.
CIARC did not estimate average lifetime exposure.
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In our opinion, all seven ofthese risk assessments suf-
fer from poor characterization of the benzene exposure
history ofthis cohort and, consequently, little faith can
be placed in the risk estimates derived therefrom. Sub-
sequent risk assessments have attempted to make im-
provements in the characterization of exposure in the
Infante/Rinsky cohort.
White, Infante, and Chu. White, Infante, and Chu(36)
performed a risk assessment based upon the data pre-
sented in Rinsky et al. (9) and Ott et al. (8). For the
Rinsky et al. cohort, the riskassessment was based solely
on the experience ofworkers who hadbeen employed for
5 years or more. It was further assumed that the upper
limit on duration of employment was 30 years, because
workers who hadbeen employed for more than 30 years
contributed less than 0.01 to the number of leukemia
deaths expected. White, Infante, and Chu made the
general assumption that during the years 1941 to 1975,
workers were exposed to benzene at the environmental
concentrations recommended during these years. They
further assumed that benzene concentrations before 1941
were 50% higher than a recommended level for 1941. On
this basis, the range of cumulative benzene concentra-
tions forworkers in the cohortwith 5 to 30 years ofexpe-
rience was estimated to be 415 ppm-years (83 ppm x 5
years) to 1500 ppm-years (50 ppm x 30 years).
The one-hit model was then selected for low-dose ex-
trapolation, primarily because of its simplicity. This
model states that excess cancerrisk(Pd) is related to the
dose (d) by the equation
Pd = [1 - exp(-fl x d)](1
- PO) (3)
where P represents the rate at which the excess proba-
bility ofleukemia increases with each increment in dose,
d represents dose, and P0 is the background risk of can-
cer. Thus, the total risk ofleukemia (Pt) to an individual
exposed to benzene isthe sum ofthebackground risk(PO)
and the risk associated with benzene:
(P, = PO + [1 - exp(-p x d)](1 - PO) (4)
The relative risk ofleukemia death in the Rinsky et al.
(9) study wasapproximatedby the SMR. It was assumed,
for the purpose of this risk assessment, that:
Pt = SMR/100(P.) (5)
On the basis ofEquations 4 and 5, it was shown that (,
the slope ofthe dose-response relation, canbe determined
as follows:
= -ln[(1 - (SMRI100)Po/(1 - Po)]Id (6)
value were determinedforthe upperandlower range
ofestimated exposure ofthe cohort. The excessleukemia
risk wasthereby estimated to be 44 to 152 per 1000 work-
ers exposed for 45 years at 10 ppm benzene and 5 to 16
per 1000workers exposed for45 years at 1 ppmbenzene.
(On the basis ofthe Ott etal. (8) study, which we consider
less suitable forrisk assessment, the excessleukemiarisk
was estimated to be 48 to 136 per 1000 workers exposed
for45 years at 10 ppm benzene and 5 to 15 per 1000work-
ers exposed for 45 years at 1 ppm benzene.)
In ourjudgment, one ofthe primary deficiencies inthe
risk assessment was its bias in its elimination from con-
sideration ofworkers in the Rinsky et al. studywhowere
exposedfor lessthan 5years. Itappearsthe 5-yearperiod
was chosen arbitrarily. Clearly, it is inappropriate to ex-
lude the observed mortality data onworkers who were
actually subject to the lowerrange ofexposure to which
the model wvill actually apply. Rather, the entire exposed
cohort and its corresponding SMR should have been used
in the assessment ofrisk ofthis worker cohort.
Further, it shouldbe realizedthattherange ofrisks es-
timatedbyWhite, Infante, and Chu onthe basis ofthese
data is highly unlikely to represent the true range of
risks. The SMR selected(2100)represented the average
SMR for the subset of workers with 5 years or more of
exposure. White, Infante, and Chu applied this average
SMR to their range of cumulative exposure estimates.
Thisaverage riskestimate,however, doesnot correspond
to the risk at either the upper or lower estimates ofex-
posure. Itwouldhave been more appropriate to have ap-
plied this average SMR to anestimate ofthe average cu-
mulative exposure of the cohort.
Review of the environmental monitoring data in the
Rinsky et al. (9) study calls into question White, Infante,
and Chu's assumption that workers were exposed to ben-
zene at the environmental concentrations recommended
duringthe timeperiods underconsideration. The datain-
dicated that in certain areas oflocation 1 (on which the
large majority of data were available), environmental
benzene concentrations wellexceededtherecommended
concentrations for the respective time period. Thus, data
contained in the study itselfsuggest thatWhite, Infante,
and Chu may have underestimated the exposure ofthe
Rinsky et al. (9) cohort.
Overall, it is our view that the White, Infante, and Chu
risk assessment, like the earlier risk assessments
described, was deficient primarily in its characterization
of exposure ofthe cohort. The method ofexposure esti-
mation applied was relatively crude in its lack ofconsid-
eration ofactual duration ofexposure ofindividuals inthe
cohort or of exposure measurement data available for
specific work operations during the years under consid-
eration. Consequently, the risk estimates derived by
White, Infante, andChu shouldbe givenless weightthan
those obtained in more recent assessments that consid-
ered such data.
Thegeneral methodologies employed inthe subsequent
risk assessments ofbenzene andleukemia, namely those
by Crump andAllen(37)and Rinsky et al. (20-21)are, in
our view, superior to those employed in the other ben-
zene risk assessments described. A description ofthese
latter assessments and their strengths and limitations is
given in the next section. We also add our own risk as-
sessment, based on a synthesis ofthe desirable features
of all available assessments.
Crump andAllen. Crump andAllen(37)made a signif-
icant improvement over earlier assessments of the
Rinsky et al. (9)cohort intheir characterization ofitsben-
zene exposure history. In their analysis, an exposurepro-
file was constructed for each worker in the Rinsky et al.
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(9) cohort. In order to accomplish this, theyused the ben-
zene measurement data provided in the Rinsky et al.
study (9), an updated data tape on the cohort, and data
provided by Rinsky, permitting the association ofwork
areas with occupational codes.
Estimates ofbenzene exposure werebasedon available
measurements in eight major areas and were derived for
seven time periods that corresponded to the years in
whichrecommended occupational benzene concentrations
were changed. Time periods were so categorized based
uponthe assumption thatthe company'sprocedureswith
respect to benzene concentrations would remain un-
changed unless revisions in the recommendations or stan-
dards had occurred. Available measurements withintime
periods were averaged, based upon the assumption that
roughly equivalent measurementprocedures would have
been used within a given time period.
In the event there were no measurements for a given
area in a given period, Crump and Allen multiplied the
estimate from the following period by the ratio of the
recommended occupational concentration for the period
to the recommended occupational concentration for the
followingperiod. Thegeneral assumption wasmade that
monitoring data from one plant location were applicable
to the other.
On the basis of these assumptions about exposure in
specific work areas during specific time intervals, esti-
mates ofcumulativebenzene exposure inppm-yearswere
determined for each worker. Crump and Allen included
dry-side workers in their analyses and recalculated the
SMRs for the cohort, both for all workers combined and
for six subgroups categorized by cumulative exposure.
Their calculations were also different from those in the
White, Infante, and Chu assessment [based on Rinsky et
al. (9)]because theyincludedfollow-upbetween 1940 and
1950, andbetween 1975 and 1978. Forthe overall cohort,
8leukemias were observed versus 2.98 expected, result-
ingin an SMR of268(p = 0.01). Mortalityfromleukemia
was dose related, with 6 ofthe 8 leukemias occurring in
the two highest cumulative dose categories.
Crump and Allen also used the data on leukemia mor-
tality from the Ott et al. (8) study for deriving their risk
estimates. The data tape from the study was furnished
to Crump and Allen so they could perform some addi-
tional calculations beyond those in the published study.
On the basis ofthis tape, the SMR for leukemia was es-
timated tobe 208(two leukemia deathsobserved/0.96 ex-
pected) versus the SMR of375estimated inthe Ott et al.
analysis. Crump and Allen made thejudgment that the
Ott et al. study, involvingonly two deaths fromleukemia
and lack of a dose-response relationship, would not be
used independently to make risk estimates, but only in
conjunction with data from other studies.
Crump and Allen also used the data set ofWong et al.
(26) in deriving some oftheir risk estimates. They indi-
cated however, that without some explanation for the
leukemia deficit in the unexposed group, the Wonget al.
study does notprovide strongevidence ofarelationship
between occupational exposure to benzene andleukemia.
Crump and Allen, however, proceeded to use the Wong
et al. data set to estimate excess leukemia risk on the
basis of cumulative dose only.
Crump andAllenfitthe available Rinsky dose-response
datatoboth the relative riskandthe absolute risklinear
dose-response models. The relative risk model assumes
that the increased age-specific mortality from an agent
is proportional to the background mortality. The absolute
risk model, on the other hand, assumes that the added
benzene mortality is the same for all ages, given equal
doses. The relative risk model applied was as follows:
E(Oi) = aEi(1 + bdi) (7)
and the absolute risk model:
E(Oi) = Ei + (a + bdi)Yi (8)
where:
E(Oi) is the expected number ofleukemia deaths in the
ith dose category;
a is a parameter which allows for the possibility that
the background leukemia rates in the cohort differfrom
those of the reference population;
Eiisthe expected number ofleukemia deaths in the ith
group based upon mortality rates in a comparison popu-
lation;
b is the potency ofbenzene for causing leukemia mor-
tality;
di is the average benzene dose in the ith group; and
Yi is the total number ofperson-years in the ithgroup.
Next, Crump and Allen described the four different
measures of dose that they selected to be fit to these
dose-response models. The first was cumulative dose,
which, in this analysis, represented cumulative dose in
ppm-years up to the beginningofthe 5-year age interval
underconsideration. The second measure wasweighted
cumulative dose, inwhich all exposures occurring in the
last 2.5 years before the beginning ofthe 5 years ofob-
servation are assumed not to affect leukemiamortality;
exposures in the next earlier 5 years are given full
weight; those in the next earlier 5 years are given 1/3
weight; and all earlier exposures are given 1/6 weight.
The weighted cumulative dose methodology was based
upon data on the latency pattern ofleukemia inJapanese
atomic bomb survivors.
The third measure was termed "window dose," in
whichfullweightisgiven toexposures duringthe 10-year
periodbetween2.5 and 12.5yearspriortothe 5-yearage
interval of interest, while exposures outside of this
10-yearwindow are ignored. This window dose measure
assumes that dosesfurtherthan 15 years inthe past have
no effect on mortality from leukemia.
Finally, peak exposure dose calculations were defined
as cumulative exposure inppm-yearsin work areaswith
daily average concentrations above 100 ppm. Exposures
to short-termpeakconcentrations were notidentifiedfor
these calculations. Astherewere no areaswithexposures
between 76 and 100 ppm, it was noted that, in effect, the
peak exposure measure assumed that only levels above
76 ppm contributed to leukemia risk.
The peak exposure measure was not used to develop
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risk estimates. This was because an analysis comparing
leukemia dose-response in workers in the Rinsky et al.
(9) study exposed to levels of benzene in excess of 100
ppm to those exposed to less than 100 ppm did not sup-
port the hypothesis that peak exposure has any effect
upon risk over that which can be explained by the con-
tribution of these exposures to cumulative dose. No at-
tempt was made to determine whetherlevels otherthan
100 ppm (to represent peak exposure) had a significant
effect.
Table 2 compares Crump and Allen's estimates ofex-
traleukemia deathsper 1000workersusingboththerela-
tive and absolute risk models and three different mea-
sures of dose. Projections were based upon maximum
likelihood estimates andthe most comprehensive dataset
available under each model.
Crump andAllen alsopresented the estimates ofextra
leukemia deaths per 1000workers basedupon the Rinsky
et al. cumulative exposure data alone, to which the rela-
tive riskmodel was applied. For40years ofexposure be-
ginning at age 20, the estimated extra leukemia deaths
were 6.6/1000 workers exposed at 1 ppm and 63/1000
workers exposed at 10 ppm. Estimates based upon the
Rinsky et al. data alone using the alternative dose mea-
sures andthe absolute riskmodel were notpresented in
the Crump and Allen paper.
Crump and Allen received a comment on their report
which suggested that some oftheir exposure estimates
may have been too high, as levels above 200 ppm, as a
time-weighted average, would have beenassociatedwith
an increased rate ofanemia in as little as 4 months, and
such an effect was not documented. CrumpandAllen de-
veloped an alternative exposure matrix torespond to this
comment, which in effect instituted a ceiling of 131 ppm
for certainjob categories. Crump andAllenindicate that
use ofthis alternative exposure matrixwill increase risks
by about25%. (Thiswould result in an excess ofapprox-
imately 8 leukemia deaths/1000 workers exposed at 1
Table 2. Estimates of extra leukemia deaths per 1,000 workers
exposed to benzene using relative risk and absolute risk models
and three exposure measures.a
40 years of exposure
beginning at age 20
Model and exposure 1 ppm 10 ppm
Relative risk model
Cumulative exposure (8,9,26) 9.5 88
(b = 0.033)
Weighted cumulative exposure (8,9) 3.0 29
(b = 0.048)
Window exposure (8,9) 1.2 12
(b = 0.035)
Absolute risk model
Cumulative exposure (8,9) 2.0 19
(b = 1.6 x 10-6)
Weighted cumulative exposure (8,9) 1.5 15
(b = 4.1 x 10-6)
Window exposure (8,9) 1.1 11
(b = 3.1 x 10-6)
'All estimates based upon maximum likelihood estimates of dose-
response slopes.
ppmfor40years, andof79leukemiadeaths/1000workers
exposed at 10 ppm for 40 years.)
Inourjudg-ment, the Crump and Allenestimatesbased
upon cumulative dose should be given the most weight.
The window exposure assumption that benzene ex-
posures more than 15 years in the pasthave no effect on
leukemiamortality seems improbable and is at variance
with data on leukemia mortality ofJapanese survivors of
the atomicbomb, in whom excess leukemiamortality has
been observed as late as 30 years after exposure. Fur-
ther, in ourjudgment, the datauponwhichtheweighted
cumulative dose measure wasreportedlybased [leukemia
mortality in Japanese atomic bomb survivors (38)], pro-
vided an insufficient basis to supportthe development of
the weighted cumulative dosemeasureforleukemia. Spe-
cifically, the relative excess ofleukemiamortality in the
bomb survivorpopulation does not appearto be indepen-
dent of age at exposure. In addition, the observations
thatrelative excessmortality decreasedby2/3 from the
second 5-year interval after exposure to the third 5-year
interval and furtherdecreasedby 1/2 in subsequentyears
apply only to the subgroup exposed at ages 30 to 44; ob-
servations for subgroups exposed in the remainingadult
age groups showed inconsistent decreases in leukemia
mortality over time.
There is little available basis upon which to form an
opinion whether the absolute or relative risk model ap-
plied by Crump and Allen is most appropriate. Crump
andAllenindicate apreferencefor therelative riskmodel
because it seems mostprobable thatthe effect ofbenzene
should be larger when the background rate ofleukemia
is higher. We tendto concurwith thispreference. On the
basis ofexpert hematological opinion submitted during
the 1986 OSHA benzene hearings, it is suggested that
there islittle supportforthe Crump andAllen alternate
exposure matrix. Specifically, the apparent absence of
deaths related to bone marrow toxicity among workers
in Pliofilm areas (i.e., casting) with estimated benzene
concentrations in excess of130ppm doesnotindicate that
such estimated concentrations were higher than actual
concentrations (39,40).
AccordingtoGoldstein, thebenzeneliteratureindicates
that even in the worst ofsituations in the past (with re-
gard to high exposure tobenzene), there were relatively
few individuals with clinically overt pancytopenia; simi-
larly, acute myelogenousleukemia has notbeen observed
inmore than 1 to2% ofsuchhighly exposedworkers(39).
Bennett observedthat the literature onbenzene-induced
aplasias and cytopenias, although extensive, doesnotper-
mitreliable prediction ofaspecific numberofsuch cases
atanygiven exposure level. Further,giventherelatively
smallnumberofPliofilmworkers (approximately50)who
experienced benzenelevelsthat one wouldgenerally as-
sociate with aplastic anemia, the apparent absence of
cases is unexceptional (40). The opinions ofthese hema-
tology experts suggest that the Crump and Allen origi-
nal exposure estimates, derivedfromindustrial hygiene
data, arepreferable to the Crump and Allen alternative
estimates (37). Thus, in ourjudgment, application ofthe
relative risk model and the original Crump andAllen cu-
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mulative dose measure to the Rinsky et al. dataprovides
the risk estimates that are the most plausible in the
Crump and Allen assessment.
Rinsky etal. In addition to the cohort analysis of1196
white male Pliofilm workers described earlier Rinsky et
al. performed a matched case-control analysis on a sub-
set of this Pliofilm worker cohort (20,21). In this analy-
sis, each ofthe 9 leukemia cases was matched to 10 con-
trols by year of birth and year first employed. This
analysis was performed in an attempt to evaluate the ef-
fect ofcertain indicators ofexposure on the relationship
between risk of death from leukemia and exposure to
benzene; to evaluate the effect ofpotential confounders
and effect modifiers on this relationship; and to identify
the functional form ofthe exposure-response relationship.
The investigators initially considered the following ex-
posure variables separately and fit a separate model for
each variable: cumulative exposure, duration ofexposure,
and average exposure rate. Cuimulative exposure, ex-
pressed in ppm-years, was reported to be the strongest
predictor of death from leukemia (p = 0.0126, 95% C.I.
- 0.0028 - 0.0224; x2 = 6.4; p = 0.011) (21).
An evaluation of the shape of the exposure response
function was performed in which several models for cu-
mulative exposure were applied. The finding indicated
that a log linear model best represented the observed
exposure-response relationship. On the basis of this
model, the equation describing the odds ratio (OR) for
leukemia in relation to cumulative benzene exposure was
reported to be OR = exp (0.0126 x ppm-years). At 45
ppm-years, themodelpredicts 5.3 excessleukemiadeaths
per 1000 workers, and at 450 ppm-years, 667 excess
leukemia deaths per 1000 workers are predicted.
The Rinsky et al. (20,21)method ofconditional logistic
regression is a valuable approach to analyzing dose-
response information, as itmakes maximal use ofthe in-
formation available on individual exposure. In its inclu-
sion ofindividual exposure levels in the statistical analy-
sis, it avoids the loss of information and resultant
imprecision that may occur in analyses that dichotomize
[e.g., the earlier linear (27,30-35) and one-hit model risk
assessments (36)] or categorize (37) cumulative benzene
exposure.
It shouldbenoted, however, thatthismethodologywill
onlyresultintruly improvedrisk estimates ifitisbased
upon sound estimates ofindividual exposure. Aswasthe
case in the Crump and Allen assessment involving in-
dividual exposure estimation, numerous assumptions
were necessarily made about past benzene exposure.
Further, complex decision rules were developed to esti-
mate exposures for individual years. The validity ofthe
assumptions and decision rules applied by both Rinsky
et al. and by Crump andAllen shouldbereconsidered in
lightofadditional relevant exposureinformation thathas
recently beenuncovered through searches conductedby
the American Petroleum Institute.
Present Authors
We have performed several additional analyses ofthe
Rinsky et al. data set(20), inwhichthe case-control, con-
ditional logistic approach was applied. Because currently
there is uncertainty regarding actual past benzene con-
centrations in the Pliofilm plants ofconcern, we have per-
formed separate analyses in which the Rinsky et al. (20)
and the Crump and Allen (37) assumptions about ex-
posure were applied.
We have also examined the Rinsky et al. (20) datatapes
and noted several inconsistencies in the case-control data.
Specifically, uponexaminationoftheworkhistories ofthe
controls selected by Rinsky et al. (20)(control set 1)itwas
noted that 15 ofthe 90 controls had 0 ppm-day cumula-
tive exposure; according to the Rinsky et al. (20) study
criteria, individuals with less than 1 ppm-day ofbenzene
exposure in Pliofilm should have been excludedfromthe
cohort.
Upon examination ofthe Rinsky et al. (20) data tapes,
itwas noted thatthe investigators hadusedinconsistent
cohort definition criteriafor the case-control and the co-
hort studies. Inthe cohort study, Rinsky etal. apparently
consideredonlya smallergroupof1196wet-sideworkers,
whereas in the case-control study, alargergroup involv-
ing 1868wet-side and dry-sideworkerswas included. We
believe it is more appropriate to consider workers from
boththe wet and dry side in the analysis, as there is evi-
dence ofbenzene exposure inboth ofthese Pliofilmwork
areas. In ourreanalysisofthe datatapes, we considered
all 1868workers in our subsequent selection ofcontrols.
We selected another group of90 controls from the co-
hort, applyingthe Rinsky et al. matchingcriteria(control
set 2). In addition, we selected a third control group,
matched according to the criteria of Rinsky et al. (date
ofbirth and date offirst employment), but applying the
additional criterion ofmatching according to plant (con-
trol set3). We elected to matchby plantbecause the two
plants were located more than 100 miles apart and be-
cause of differences in non-Pliofilm benzene exposure,
which may have influenced plant-specific mortality pat-
terns.
Table 3presents our estimates ofthe additional lifetime
leukemiamortality risks (assuming abackground leuke-
miamortality risk of0.0071)forworkers exposed to ben-
zene at 1 ppmfor45years(45ppm-years) and 10ppmfor
45 years (450 ppm-years), usingthe various exposure as-
sumptions and control sets described above. The Crump
and Allen I exposure assumptions are those originally
derivedby these investigators. The Crump andAllen II
exposure assumptions are their alternate estimates in
which a ceilingof 131 ppm for eachjob category was en-
forced.
Our analyses demonstrate that use ofthe Crump and
Allen I (37) exposure assumptions instead of those of
Rinsky etal. (20)willreduce the leukemiamortality risks
projected substantially (by factors of approximately 10
and77, at45 and450ppm-years, respectively). Further,
use ofcontrol groups in which more stringent and alter-
native matching criteria are applied will also affect the
estimates of risk.
We propose that selection of controls from the larger
cohort, which included both the wet- and dry-side work-
ers, is appropriate. We believe our additional criterion of
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Table 3. Summary of present authors' analysis of Rinsky et al. (19) data using conditional logistic regression
and alternative exposure assumptions and control groups.
Additional lifetime leukemia deaths per 1000
workers due to benzene exposure
Exposure assumptions Control seta 45 ppm-years 450 ppm-years
Rinsky et al. (20) 1 5.1 (0.83-11.7)b 635 (15.6-986)
Rinsky et al. controls matched on:
date of birth
date of entering Pliofilm
Rinsky et al. (20) 2 6.4 (1.2-14.7) 819 (26.4-991)
Present authors controls matched on:
date of birth
date of entering Pliofilm
Rinsky et al. (20) 3 4.2 (1.0-8.7) 449 (21.3-953)
Present authors controls matched on:
date of birth
date of entering Pliofilm plant
Crump and Allen (37) I 1 0.5 (0.13-1.0) 8.3 (1.4-20.4)
Crump and Allen (37) I 2 0.7 (0.1-1.3) 11.0 (1.4-30.9)
Crump and Allen (37) I 3 0.5 (0.1-1.0) 7.9 (1.1-20.4)
Crump and Allen (37) II 1 1.3 (0.3-2.3) 29.8 (4.2-106)
Crump and Allen (37) II 2 1.6 (0.3-3.1) 47.0 (4.0-218)
Crump and Allen (37) II 3 1.2 (0.3-2.3) 27.8 (3.3-103)
aControl sets: 1) Rinsky et al. controls matched on date of birth, date entering Pliofilm work; 2) present authors controls matched on date of
birth, date entering Pliofilm work; 3) present authors controls matched on date of birth, date entering Pliofilm work, and plant.
bNumbers in parentheses are 95% confidence intervals.
matching by plant is also appropriate, because it
eliminates potential location bias. We therefore have a
preference for the risk estimates based upon our control
set 3. In the following section, we will describe additional
data on the benzene exposure history at the Pliofilm
plants studied by Rinsky et al. These data are ofimpor-
tance because they provide a basis for selection from or
adjustment of the various benzene risk assessments.
Additional Factors Regarding
Benzene Exposure in the Rinsky
Cohort
There are anumber ofadditional factors that were not
accounted for in the assessment ofthe total benzene ex-
posure ofthe Rinsky et al. Pliofilm cohort that may sig-
nificantly affect the estimates ofriskprojected on its ba-
sis. First, employment ofmembers ofthe cohort in the
non-Pliofilmjobs involvingbenzene exposure was not ac-
counted for in any of the exposure assessments of the
Rinsky et al. cohort. Preliminary review ofthe subset of
thejob histories ofthe cohort(withinthe Goodyearplant)
indicates that a large percentage of the workers also
worked in non-Pliofilm jobs in other areas of the plant.
These jobs dated back to the early 1900s and involved
areas ofthe plant (e.g., tire building, cement mixing) for
which there is evidence that pure- or high-benzene con-
centration solvents were used up to at least 1942.
Areview oftheliteraturehasindicatedthat intheearly
decades ofthe 20th century, rubberworkersappeared to
be highly exposed to benzene-containing solvents and
rubber cements(41). These substanceswere oftenapplied
by hand or inrelatively poorly ventilated environments.
Based upon a 1924 survey ofthe industry (42), benzene
vapor exposures ofrubber workers ranged between ap-
proximately 100 and 900 ppm. A survey of four rubber
plants in 1942 reported benzene levels ranging from 10
to 350 ppm (43).
Wilson(44) described the bloodexaminations and symp-
tomatology of 1104 workers at Goodyear who had used
benzol. He indicated that the concentration ofbenzol to
which patients seen at the company hospital were ex-
posed varied between 50 and 500 ppm, with an average
concentration of 100 ppm; occasional sharp exposures of
500 to 1000 ppm benzol were also cited. Ofthis group of
1104 workers, 83(7.5%) showed mild blood changes, and
25(2.2%) showed severe blood changes(aplastic anemia)
with symptoms ofsevere benzene intoxication. Three of
these 25 patients died as a result ofthe aplastic anemia.
At a 1942 conference on health hazards in the rubber in-
dustry, Conn ofGoodyear specifically cited the spreader
operation of Pliofilm production as an area of elevated
benzene concentrations thatresulted in two deaths from
severe aplasticanemia(45). He indicated thatpriorto the
introduction ofventilation measures, benzene exposures
rangedfrom 500to 700 ppm directly above the spreaders.
Data contained in the work histories ofthe Rinsky et al.
Goodyearcohortindicate that duringthe 1940s anumber
of hospitalizations and fatalities secondary to acute ex-
posure to highlevels ofbenzene also occurred in the neu-
tralizer area ofthe Pliofilmplant(46). This is particularly
noteworthy inregardto the Rinsky etal. cohort, inwhich
6 of the 9 leukemia cases worked in the spreader-
neutralizer area during the 1940s, when other workers
performing the samejobs sometimes suffered fatal blood
dyscrasias. In addition, Davis (42), who was assistant
medical director ofGoodyear, wrote ofexamining about
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7000 workers who had used various substances contain-
ingbenzene overa 12-yearperiod. These reports suggest
thatGoodyearusedbenzene in various operations atleast
as early as 1917 to 1942 or later.
A preliminary analysis of the work histories of the
leukemia cases and controls selected by Rinsky et al. (20)
indicated that the 9 cases had substantially more poten-
tial exposure to benzene than did the 90 matched con-
trols, both in Goodyear non-Pliofilm and Pliofilm opera-
tions. Overall, itwas observed that the cases worked, on
average, nearly three times as long as controls in solvent-
related non-Pliofilmjobs, inwhich benzene exposure was
likely. When the analysis was broken down by time
periods, this distinction between cases and controls was
greatest during the years prior to 1942, when the use of
high benzene content solvents was most prevalent (48).
Another factor not considered in the available risk as-
sessments was the contribution of dermal exposure to
benzene, bothwithin Pliofilm and non-Pliofilmjobs atthe
Goodyearplants. There wastestimonypresented during
the 1977 OSHAhearings that certain workers in Pliofilm
were sometimes drenched inbenzene. Further, in astudy
recently conducted by NIOSH investigators (49), it was
estimated thatworkers in tirebuilding(anon-Pliofilmjob
in which some ofthe Pliofilmworkers had spent some of
theiryears atGoodyear) have 150 contacts ofthepalmar
surface perworkdayinvolvingexposure tobenzene in so-
lution. Assuming a 0.5% benzene content in the solvent,
150 cm2 ofexposedpalmar surface, 6.25 .iL solvent/cm2,
0.88 g/mL benzene density, and 1% dermal absorption,
they estimated that 6.19 mgbenzene wouldbe absorbed
per workday. Additional studies by Maibach (50-52),
Franz (53), and Hanke et al. (54), however, suggest that
the dermal absorption value appliedby Susten et al. (49)
waspossibly toohighby afactorofapproximately 3. This
would lower the amount of benzene absorbed in tire
building in which 0.5% benzene in solvent is presently
used to approximately 2 mg/day (vs. approximately 15
mg/workday absorbed from inhalation of 1 ppmfor8 hr)
(55). If 100% benzene were used, as was likely the case
in certainjobspriorto 1942, the amount absorbedbythe
dermal routewouldincrease by afactorofapproximately
200, to a level of approximately 400 mg/workday (56).
The American Petroleum Institute has made some
preliminary estimates ofthe potential effect upon leuke-
miariskofthe addition ofnon-Pliofilm airborne and der-
mal benzene exposures to the Pliofilm-specific benzene
exposure estimates applied inthe case-control analyses.
For these analyses, three different sets ofexposure as-
sumptions were developedforthe non-Pliofilmjobs ofthe
workers, representing potential low, moderate, or high
benzene exposure. At the time when these calculations
wereperformed, NIOSH hadonlymade available a sub-
set ofthe workhistories ofthe Rinsky etal. cohort. Con-
sequently, toperform these calculations itwasnecessary
to develop aprocedure inwhichnon-Pliofilm exposure of
workers for whom no workhistory was available was es-
timatedfrom theexperience ofworkersforwhom awork
history was available (57).
These analyses suggestedthatthe additional considera-
tion ofnon-Pliofilm airborne and dermal exposure ofthe
Rinsky et al. (20) cohort could result in a substantial
lowering ofthe excess leukemiarisk associatedwithben-
zene exposure. Forexample, onthebasis ofthe highnon-
Pliofilm benzene exposure assumptions, excess risk as-
sociatedwith45years ofexposure at 1 ppminthe work-
place would decrease by a factor of 17 assuming the
Rinsky et al. (20) exposure matrix, and by a factor of 2
assuming the Crump and Allen I exposure matrix. It
should be noted that these estimates are by necessity
crude astheywerebased onlimited additionalindustrial
hygiene data for non-Pliofilm work areas and because
complete work histories were not available on all mem-
bers of the cohort at the time of the analysis.
Nevertheless, these estimates suggest that the lack of
consideration ofinhalation and dermal absorption ofben-
zene in non-Pliofilm areas in calculating cumulative ex-
posure ofthe Rinsky et al. cohortresultedin anunderes-
timation oftotal exposure andpossibly an overestimation
ofrisk. API intends to investigate additional sources of
information on airborne benzene levels in non-Pliofilm
areas and on the extent of dermal exposure in Pliofilm
and non-Pliofilmjobs. Such datawillbe incorporated into
future assessments ofbenzene-associated leukemia risk.
Conclusions About Leukemia Risk
When epidemiological data ofreasonably good quality
are available, these data shouldbe used to assess risk to
human populations. In the case ofbenzene leukemogen-
esis, the Rinsky et al. studyofbenzene-exposed Pliofilm
workers (20,21), because ofitsrelativelylarge amount of
exposure information, appears the best suited for assess-
ingquantitativelytheleukemia riskofbenzene. The risk
assessments thathave made use ofthe Rinsky et al. data
therefore form the basis ofour conclusions aboutthe risk
of leukemia associated with occupational benzene ex-
posure.
We have reviewed seven earlier benzene risk assess-
ments ofthe Rinsky et al. cohort that employed the lin-
ear model (27,30-35); the assessment ofWhite, Infante,
and Chu that employed the one-hit model(36); the Crump
andAllen assessment thatusedboththerelative and ab-
solute risk linear models (37); the Rinsky et al. assess-
mentthatusedlinearlogisticregressionfor acase-control
subset ofthe cohort (20,21); and the present assessment
that used linear logistic regression with various modifi-
cations to the Rinsky et al. (20) case-control analysis.
The earlier assessments, and that of White, Infante,
and Chu (36), in ourjudgment, all inadequately charac-
terized the benzene exposure history ofthe cohort, and
consequently, estimates of risk derived from these as-
sessments should be considered more limited than those
of Rinsky et al. (20,21), Crump and Allen (37), and the
present report. Ourconclusions aboutbenzene-associated
leukemia risk are therefore based upon these three lat-
ter analyses.
The Crump andAllen(37)andthe Rinsky et al. (20,21)
assessments should be considered preferable to the
earlier assessments as theybothattempted to character-
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ize the benzene exposure histories ofindividual members
ofthe Pliofilm cohort, as opposed to making generaliza-
tions about benzene exposure of the cohort as a whole.
The manner in which exposure in individual work areas
ofthe Pliofilm plants was assessed appears to be the fac-
tor ofgreatest influence on the number of excess leuke-
mia deaths projected in these various assessments. The
Crump and Allen (37) methodology of exposure assess-
ment differed from that ofRinsky et al. (20,21) in a num-
ber of respects. Crump and Allen calculated time-
weighted average benzene levels over seven multiyear
time periods, whereas Rinsky et al. derived single-year
values on the basis of actual values or by linear interpo-
lation. In cases where there were no data available for
earlier time periods, Rinsky et al. extrapolated the ben-
zene concentrations for the earliest yearback to theplant
opening. In fact, for 3 ofthe 10 exposure classes consid-
eredby Rinsky et al., levelsfrom the 1960s were extrapo-
latedbackinto the 1930s. Crump andAllen, inthe event
that there were no measurements for a given area for a
given period, multiplied the estimate from the following
period by the ratio ofthe occupational standard or recom-
mendation for the period to that ofthe occupational stan-
dard or recommendation of the following period.
Both groups used data from location 1 as a surrogate
for location 2. Crump and Allen used data from the two
locations interchangeably, whereas Rinsky et al. applied
datafromlocation2only to thislocation. Rinsky etal. also
excluded from their estimates data documenting high
benzene levels inthe storage areaoftheplant; these were
included by Crump and Allen in their average exposure
category. These various differences resulted in the ex-
posure estimates of Crump and Allen being generally
higher than those ofRinsky et al. forthe majority ofthe
job titles and time periods covered.
In the absence of additional monitoring data, it is not
possible to render ajudgment as to which methodology
best estimates the absolute exposuresexperienced bythe
cohort. As described above, a major difference between
Rinsky et al. and Crump and Allen was in their metho-
dologies for estimating exposures in the earlier years,
when no industrial hygiene data were available. The re-
sult ofthis methodologic difference is that the Crump and
Allen estimates for the early years generally exceeded
those of more recent years, while the Rinsky et al. esti-
matesforearly years were often the same asfor more re-
cent years. We have a preference for the Crump and Al-
len methodology for estimating relative benzene
exposures duringthe earlier years, as it seems moreplau-
sible that such exposures were higher than those mea-
sured more recently. A recent analysis in which an at-
tempt was made to correlate hematology data of the
Pliofilm cohort with both the Rinsky et al. and the Crump
and Allen exposure assumptions tends to further support
the methodology applied by Crump and Allen. In this
analysis, the Crump and Allen exposure estimates cor-
related more strongly than the Rinsky et al. estimates
with fluctuations in the white and red blood cell counts
of the cohort (58). Of the two exposure matrices pre-
sented by Crump and Allen, we prefer the original ma-
trix. As detailedearlier, the available dataon humanben-
zene toxicity provide some support for this exposure
matrix, which was derived from existing industrial hy-
giene data.
We adopted the exposure methodologies developed by
both Crump and Allen and Rinsky et al. in our estima-
tions of benzene leukemia risk. Our analyses used the
matched case-control conditionallogisticregressionmeth-
odology. We assessed the effect of applying the Crump
andAllen exposure methodologyto the Rinsky etal. case-
control data set. We selectedthree additional sets ofcon-
trols: thefirst applying Rinsky's criteriaofmatchingby
date ofbirth and date offirstemploymentin Pliofilm; the
secondinwhichthe controlswere matchedbyplantin ad-
ditionto the Rinskymatchingcriteriaofdate ofbirthand
date of first employment in Pliofilm; and the third in
which controls were matched by the Rinsky criteria,
plant, and date of last employment.
Table 4presents the range ofadditional lifetime leuke-
miadeathsper 1000workers associatedwithoccupational
benzene exposure whichwereprojectedin the variousas-
sessments in which the Crump and Allen (37) and the
Rinsky et al. (20,21) exposure methodologies were ap-
plied. In all cases, risk was associated with cumulative
benzene exposure. Basedonthistable at 10ppmbenzene
exposure for 45 years (450 ppm-years), a range of7.9 to
819 additional leukemia deaths per 1000 workers would
be expected. Byreducingthe OSHAPELto 1 ppm, again
assuming 45 years ofexposure (45 ppm-years), approxi-
mately 0.5to 7additional leukemia deathsper 1000work-
ers would be expected.
We have apreferenceforthe conditionallogisticregres-
sion approach adopted by Rinsky et al. (20,21) and sub-
sequentlyby ourselves because it makes maximal use of
the datapointsavailable. We alsopreferthe strictcriteria
formatching that we have used, in which the cases were
matched by date of birth, date of first employment in
Pliofilm, and plant (control set 3). We prefer the use of
Crump and Allen's exposure matrices because they, in ef-
fect, assume exposures in earlier years exceeded those
in later years. Available data on benzene toxicity in hu-
mans appear to provide greater support for Crump and
Allen's original exposure matrix. This methodology and
choice ofcontrolgroup and exposure assumptions results
in our preferred estimate of0.5 excess leukemia deaths
per 1000workersexposedfor45years to 1 ppmbenzene,
and 7.9 excessleukemiadeathsper 1000workersexposed
for 45 years to 10 ppm benzene.
It should be noted, however, that these estimates do
not take into account the influence ofbenzene exposure
ofworkers via inhalation and dermal absorption in non-
Pliofilm areas ofthe plants studied by Rinsky et al. On
the basis ofourpreliminaryanalyses, itis suggestedthat
accountingfor such exposures will likely result in a sub-
stantiallowering ofthe occupationalleukemiariskswhich
were estimated on the basis of this study.
Additional dataonthe extentofinhalation and dermal
exposure to benzene in the Rinsky et al. cohort may be
revealed throughthe analysis ofGoodyearworkers' his-
tory records recently made available by NIOSH and by
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Table 4. Comparison of available benzene risk assessments in which Crump and Allen (37) or
Rinsky et al. (20,21) exposure assumptions were applied.
Additional lifetime leukemia risk per 1000 workers
Exposure due to benzene exposure
Risk assessment Data set used assumptions Model applied 45 ppm-years 450 ppm-years
Rinsky et al. (21) Rinsky et al., 1986 Rinsky et al. 1986 Conditional 5.3 667
case-control analysis cumulative exposure logistic
estimated on an regression
individual basis
Present authors ia Rinsky et al., 1985 Rinsky et al. 1985 Conditional 4.2-6.4 449-819
alternate case- cumulative exposure logisitic
control analysis estimated on an regression
individual basis
Present authors Iia Rinsky et al., 1985 Crump and Allen Conditional 0.5-0.7 7.9-11.0
alternate case- 1984-I cumulative logistic
control analysis exposure estimated regression
on an individual
basis
Present authors IIIa Rinsky et al., 1985 Crump and Allen Conditional 1.2-1.6 27.8-47.0
alternate case- 1984-II cumulative logistic
control analysis exposure estimated regression
on an individual
basis
Crump and Allen (37) Rinsky et al., 1981 Crump and Allen Relative 6.6 (for 40 ppm-years) 63 (for 400 ppm-years)
cohort study (8 1984-I cumulative risk beginning at age 20 beginning at age 20
leukemias) exposure estimated (linear)
on an individual
basis
aRanges reflect the use of three different control groups.
pursuing additional sources ofdata ofpast exposure prac-
tices in the industry. Clearlyfurtherinvestigation ofthe
actual extent ofadditional benzene exposures ofthe co-
hort is warranted in order to improve susbsequent esti-
mates of the leukemia risk associated with human ex-
posure to benzene.
This paper is based upon work performed forthe American Petroleum
Institute, whose support is gratefully acknowledged.
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